Prelude Capital Management, LLC Trans Medics Group, Inc. Transaction History

Prelude Capital Management, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$36.74 - $81.08 $105,590 - $233,023	2,874 New	2,874 $226,000
Q4 2019 Feb 14, 2020	SELL	$16.61 - $21.64 $158,990 - $207,138	-9,572 Closed	0 $0
Q3 2019 Nov 14, 2019	BUY	$20.27 - $28.93 $35,472 - $50,627	1,750 Added 22.37%	9,572 $227,000
Q2 2019 Aug 14, 2019	BUY	$22.36 - $30.41 $174,899 - $237,867	7,822 New	7,822 $227,000

347

30.6M

671K

858K

Ticker TMDX
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 31,831,400
Market Cap $2.18B
Description
TransMedics Group, Inc., a commercial-stage medical technology company, engages in transforming organ transplant therapy for end-stage organ failure patients in the United States and internationally. The company offers Organ Care System (OCS), a portable organ perfusion, optimization, and monitoring system that utilizes its proprietary and custo...

Get notified when there are updates to the investment portfolio of Prelude Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Prelude Capital Management, LLC with notifications on news.